Compound information
- Natural Products
- NACP65968
- Molecular Formula
- C26H40N6O6
- Molecular Weight
- 532.300933 g/mol
- Structure
-
- IUPAC Name
- 2-[[1-[2-(benzyloxycarbonylamino)-4-methyl-pentanoyl]piperidine-4-carbonyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C26H40N6O6/c1-17(2)15-21(31-26(37)38-16-18-7-4-3-5-8-18)23(34)32-13-10-19(11-14-32)22(33)30-20(24(35)36)9-6-12-29-25(27)28/h3-5,7-8,17,19-21H,6,9-16H2,1-2H3,(H,30,33)(H,31,37)(H,35,36)(H4,27,28,29)
- InChI Key
- KFDGYYKEYONTAZ-UHFFFAOYSA-N
- SMILES
- O=C(OCC=1C=CC=CC1)NC(C(=O)N2CCC(C(=O)NC(C(=O)O)CCCNC(=N)N)CC2)CC(C)C
- CAS
- SuperClass
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- SubClass
- Amino acids, peptides, and analogues
- Source
- CNP0341668
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 38 | Ring Count | 2 |
Heteroatom Count | 12 | Rotatable Bond Count | 13 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 6 |
Topological Polar Surface Area | 186.94 Å2 | LogP | 0.264 |
LogS | -2.59 | LogD | 0.816 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.007 | Pgp substrate | 0.999 |
HIA | 0.0 | F20 % | 0.882 |
F30 % | 0.0 | Caco-2 | -6.854 |
MDCK | -5.906 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.725 | PPB | 70.021 |
VD | 0.237 | Fu | 0.551 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.353 |
CYP2A6 substrate | 0.172 | CYP2B6 substrate | 0.398 |
CYP2C19 inhibitor | 0.031 | CYP2C19 substrate | 0.248 |
CYP2C8 substrate | 0.428 | CYP2C9 inhibitor | 0.235 |
CYP2C9 substrate | 0.037 | CYP2D6 inhibitor | 0.011 |
CYP2D6 substrate | 0.176 | CYP2E1 substrate | 0.261 |
CYP3A4 inhibitor | 0.03 | CYP3A4 substrate | 0.117 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.686 | CL | 2.963 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.199 | Hepatotoxicity | 0.342 |
Mutagenicity | 0.013 | Rat Oral Acute Toxicity | 0.049 |
FDAMDD | 0.15 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.002 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.072 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.41 | IGC50 | 2.053 |
LC50FM | -2.661 | LC50DM | 1.244 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.389 | NR-AR-LBD | 0.289 |
NR-AhR | 0.003 | NR-Aromatase | 0.022 |
NR-ER | 0.325 | NR-ER-LBD | 0.374 |
NR-PPAR-gamma | 0.379 | SR-ARE | 0.217 |
SR-ATAD5 | 0.315 | SR-HSE | 0.175 |
SR-MMP | 0.008 | SR-p53 | 0.053 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.